Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,349
  • Shares Outstanding, K 57,816
  • Annual Sales, $ 27,470 K
  • Annual Income, $ -20,370 K
  • 60-Month Beta 1.54
  • Price/Sales 0.38
  • Price/Cash Flow N/A
  • Price/Book 1.31
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.15 +11.33%
on 05/31/19
0.22 -23.18%
on 05/16/19
-0.04 (-20.69%)
since 05/14/19
3-Month
0.15 +11.33%
on 05/31/19
0.33 -48.71%
on 04/09/19
-0.09 (-33.78%)
since 03/14/19
52-Week
0.15 +11.33%
on 05/31/19
1.30 -87.00%
on 09/21/18
-0.90 (-84.21%)
since 06/14/18

Most Recent Stories

More News
LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space

The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resources.

ICLR : 142.91 (-1.47%)
DGX : 101.03 (+0.17%)
LH : 166.39 (-0.96%)
CGIX : 0.17 (-5.59%)
Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced...

PPCB : 0.0073 (-8.75%)
CGIX : 0.17 (-5.59%)
Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics, molecular markers and data solutions, today announced financial...

CGIX : 0.17 (-5.59%)
Demand for Cancer Treatment Remains High Despite Improving Survivability Rates

Deaths related to cancer dropped by 27% in the past quarter-century, meaning that 2.6 million fewer people died due to cancer during that time period, according to a report by the American Cancer Society....

ABIO : 6.49 (-2.84%)
SESN : 1.70 (-7.10%)
NAVB : 0.68 (-31.36%)
SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
CGIX : 0.17 (-5.59%)
Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced the pricing of a public...

CGIX : 0.17 (-5.59%)
Cancer Genetics Issues Letter to Shareholders

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today published a letter to shareholders...

CGIX : 0.17 (-5.59%)
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced the pricing of an underwritten...

CGIX : 0.17 (-5.59%)
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced that it intends to offer...

CGIX : 0.17 (-5.59%)
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the appointment of William Finger...

CGIX : 0.17 (-5.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade CGIX with:

Business Summary

Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated...

See More

Key Turning Points

2nd Resistance Point 0.20
1st Resistance Point 0.18
Last Price 0.17
1st Support Level 0.16
2nd Support Level 0.15

See More

52-Week High 1.30
Fibonacci 61.8% 0.86
Fibonacci 50% 0.73
Fibonacci 38.2% 0.59
Last Price 0.17
52-Week Low 0.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar